Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896115 · ClinicalTrials.gov registry record · NA
CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01896115 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 40 participants.
The verdict
NCT01896115, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of the study is to compare different deep brain stimulation (DBS) settings using the commercially approved Boston Scientific Neuromodulation Vercise system.
Interventions
- DEVICE Vercise DBS settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01896115
The ClinicalTrials.gov registry entry for NCT01896115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vercise DBS settings is the first listed.
NCT01896115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01896115 about?
NCT01896115 is a clinical study titled "CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation". The objective of the study is to compare different deep brain stimulation (DBS) settings using the commercially approved Boston Scientific Neuromodulation Vercise system.
What is the current status of trial NCT01896115?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01896115?
The interventions under investigation include: Vercise DBS settings (DEVICE).
Who is sponsoring clinical trial NCT01896115?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.